_version_ 1784782174506975232
author Dimeglio, Chloé
Trémeaux, Pauline
Herin, Fabrice
Da-Silva, Isabelle
Porcheron, Marion
Martin-Blondel, Guillaume
Gernigon, Caroline
Chapuy-Regaud, Sabine
Villars, Hélène
Izopet, Jacques
author_facet Dimeglio, Chloé
Trémeaux, Pauline
Herin, Fabrice
Da-Silva, Isabelle
Porcheron, Marion
Martin-Blondel, Guillaume
Gernigon, Caroline
Chapuy-Regaud, Sabine
Villars, Hélène
Izopet, Jacques
author_sort Dimeglio, Chloé
collection PubMed
description
format Online
Article
Text
id pubmed-9439860
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94398602022-09-06 Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population Dimeglio, Chloé Trémeaux, Pauline Herin, Fabrice Da-Silva, Isabelle Porcheron, Marion Martin-Blondel, Guillaume Gernigon, Caroline Chapuy-Regaud, Sabine Villars, Hélène Izopet, Jacques J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-12 2022-09-03 /pmc/articles/PMC9439860/ /pubmed/36064047 http://dx.doi.org/10.1016/j.jinf.2022.08.040 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Dimeglio, Chloé
Trémeaux, Pauline
Herin, Fabrice
Da-Silva, Isabelle
Porcheron, Marion
Martin-Blondel, Guillaume
Gernigon, Caroline
Chapuy-Regaud, Sabine
Villars, Hélène
Izopet, Jacques
Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
title Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
title_full Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
title_fullStr Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
title_full_unstemmed Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
title_short Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
title_sort post-vaccination sars-cov-2 antibody kinetics and protection duration against omicron in elderly population
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439860/
https://www.ncbi.nlm.nih.gov/pubmed/36064047
http://dx.doi.org/10.1016/j.jinf.2022.08.040
work_keys_str_mv AT dimegliochloe postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation
AT tremeauxpauline postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation
AT herinfabrice postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation
AT dasilvaisabelle postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation
AT porcheronmarion postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation
AT martinblondelguillaume postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation
AT gernigoncaroline postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation
AT chapuyregaudsabine postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation
AT villarshelene postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation
AT izopetjacques postvaccinationsarscov2antibodykineticsandprotectiondurationagainstomicroninelderlypopulation